pbl from myeloma patients caused 30 to 80 percent chromium-51 release from tanned chromium-labeled plasma cell extract-coated crbc targets , whereas pbl from normal patients or patients with benign plasmacytosis caused only 10 to 25 percent chromium-51 release .
C0026764
myeloma
C0032112
plasma cell